UNICA IRIS Institutional Research Information System

MACCIO', ANTONIO PIETRO MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 115.324
NA - Nord America 8.881
AS - Asia 1.284
AF - Africa 19
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 125.538
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 112.703
US - Stati Uniti d'America 8.837
UA - Ucraina 908
CN - Cina 824
SE - Svezia 681
DE - Germania 337
GB - Regno Unito 247
SG - Singapore 238
FI - Finlandia 213
FR - Francia 82
VN - Vietnam 69
KR - Corea 59
IN - India 42
CA - Canada 41
RU - Federazione Russa 34
NL - Olanda 25
IE - Irlanda 21
IR - Iran 13
ES - Italia 12
BE - Belgio 11
EU - Europa 9
TH - Thailandia 8
BR - Brasile 7
BG - Bulgaria 6
CH - Svizzera 6
AR - Argentina 5
AT - Austria 5
CZ - Repubblica Ceca 5
RO - Romania 5
TR - Turchia 5
DK - Danimarca 4
DZ - Algeria 4
EE - Estonia 4
EG - Egitto 4
HK - Hong Kong 4
ID - Indonesia 4
JP - Giappone 4
PH - Filippine 4
GR - Grecia 3
HU - Ungheria 3
MU - Mauritius 3
PL - Polonia 3
AU - Australia 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
CM - Camerun 2
HR - Croazia 2
MG - Madagascar 2
MX - Messico 2
NP - Nepal 2
PT - Portogallo 2
SC - Seychelles 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BZ - Belize 1
EC - Ecuador 1
LT - Lituania 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 125.538
Salva come PNG Salva come JPEG
Città #
Cagliari 111.903
Fairfield 1.282
Woodbridge 1.097
Houston 749
Chandler 624
Ashburn 575
Nyköping 545
Ann Arbor 534
Seattle 532
Jacksonville 517
Wilmington 504
Cambridge 419
Uta 261
Dearborn 224
Boardman 220
New York 169
Nanjing 164
Boston 144
Beijing 123
Singapore 118
San Diego 89
Helsinki 81
Shanghai 76
Dong Ket 68
Guangzhou 59
Menlo Park 57
Milan 56
Shenyang 49
Redwood City 43
Seoul 42
London 41
Nanchang 41
Changsha 38
Hebei 32
Rome 32
Toronto 31
Jiaxing 30
Pune 29
Los Angeles 28
Norwalk 28
Tianjin 27
Verona 27
Jinan 25
Mountain View 22
Orange 22
Zhengzhou 17
Auburn Hills 16
Sassari 14
Hangzhou 13
Phoenix 13
Ningbo 12
Brussels 11
Kunming 10
Wuhan 10
Hefei 9
Saint Petersburg 9
Atlanta 8
San Francisco 8
Bangkok 7
Chicago 7
Taizhou 7
Washington 7
Amsterdam 6
Dublin 6
Kilburn 6
Barcelona 5
Brandizzo 5
Falls Church 5
Islington 5
Rockville 5
Vienna 5
Augusta 4
Berlin 4
Chiswick 4
Hounslow 4
Philadelphia 4
Redmond 4
San Mateo 4
Sofia 4
Somma Vesuviana 4
Tonara 4
Torino 4
Assago 3
Athens 3
Copenhagen 3
Council Bluffs 3
Courtice 3
Den Haag 3
Detroit 3
Florence 3
Fuzhou 3
Gunpo 3
Jakarta 3
Lanzhou 3
Salerno 3
Scottsdale 3
Sesto Fiorentino 3
Tabriz 3
Tallinn 3
Trento 3
Totale 122.101
Salva come PNG Salva come JPEG
Nome #
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.171
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 2.327
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.259
Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases 2.257
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.079
Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report 2.076
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 1.972
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 1.921
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 1.909
A PET-positive rapidly growing mass of the abdominal wall after cesarean section with an unexpected diagnosis of vernix caseosa granuloma: a case report 1.843
Advances in pharmacologic strategies for cancer cachexia 1.763
Combined laparoscopic excisional surgery for synchronous endometrial and rectal adenocarcinoma in an obese woman 1.761
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.744
Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. 1.679
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.669
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.640
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.636
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer 1.629
Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up 1.620
Future prospects for PD-1 targeting, macrophage infiltration, and IDO pathway activation in patients with sarcomas 1.610
Successful laparoscopic management of a giant ovarian cyst 1.596
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study 1.578
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.577
A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer 1.568
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.557
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.529
Surprising results of a supportive integrated therapy in myelofibrosis 1.479
Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures 1.461
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.439
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.433
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.406
Laparoscopic hysterectomy as optimal approach for 5400 grams uterus with associated polycythemia: A case report 1.397
An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report 1.319
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.308
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes 1.254
Feasibility and safety of total laparoscopic hysterectomy for uteri weighing from 1.5 kg to 11.000 kg 1.251
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.218
(0) Save to: more options IMPROVEMENT OF PHYSICAL ACTIVITY AS AN ALTERNATIVE OBJECTIVE VARIABLE TO MEASURE TREATMENT EFFECTS OF ANTI CACHEXIA THERAPY IN CANCER PATIENTS 1.145
Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer 1.039
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.033
null 998
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 885
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 869
Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy 857
Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer 837
null 819
Blocking inflammation to improve immunotherapy of advanced cancer 813
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients 792
Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients 791
Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity 789
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases 789
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications - a review 785
Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer 754
Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report 751
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 716
Three cases of laparoscopic myomectomy performed during pregnancy for pedunculated uterine myomas 716
null 709
Successful pregnancy following myomectomy of a giant uterine myoma: role of a combined surgical approach 692
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 680
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 672
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 670
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 669
Antioxidant agents alpha lipoic acid, N-Acetyl cysteine and MESNA (2-mercaptoethane sulfonate) are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients 663
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 661
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 654
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 649
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 615
Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients 603
Experimental drugs for chemotherapy-and cancer-related anemia 576
Randomised Phase III Clinical Trial of a Combined Treatment With Carnitine plus Celecoxib +/- Megestrol Acetate for Patients With Cancer-related Anorexia/cachexia Syndrome 570
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 560
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 559
Managing cancer-related anorexia/cachexia 539
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 532
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 527
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 526
Novel technique of extracorporeal intrauterine morcellation after total laparoscopic hysterectomy: Three emblematic case reports 521
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 514
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 509
Multitargeted treatment of cancer cachexia 499
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 490
Cachexia and oxidative stress in cancer: an innovative therapeutic management 487
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 474
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 471
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 470
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 469
The mechanism of cancer cell death by PARP inhibitors goes beyond DNA damage alone 468
Management of anemia of inflammation in the elderly 467
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 465
Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series 462
Current pharmacotherapy options for cancer anorexia and cachexia 462
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 457
Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients 453
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life 451
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 449
Inflammation and ovarian cancer 444
Cancer related anorexia/cachexia (CACS) and oxidative stress: an innovative approach beyond current treatment 440
Phase II study with antioxidants, both in the diet and supplemented pharmaco-nutritional support, progestagen and anti-cox-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 439
Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer 437
Antioxidant therapy for the treatment of oxidative stress associated to cancer and cancer-related anorexia/cachexia 435
Totale 102.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018.769 0 0 222 567 6.966 4.728 2.677 823 562 446 493 1.285
2020/202131.686 1.045 1.043 1.398 6.771 6.467 4.501 3.242 2.424 776 1.621 1.487 911
2021/20227.047 551 514 450 439 724 447 469 481 607 538 702 1.125
2022/202313.231 1.055 1.398 1.181 1.004 925 1.439 748 1.437 967 980 1.354 743
2023/202415.847 999 643 533 1.065 1.529 2.830 2.205 1.006 757 1.074 1.672 1.534
2024/20257.688 2.466 3.754 1.468 0 0 0 0 0 0 0 0 0
Totale 126.014